Company Filing History:
3 out of 61 
3 out of 12 Years Active: 2024-2025
Title: Michal Abram: Pioneer in Neurological Treatment Innovations
Introduction
Michal Abram, an innovative inventor based in Cracow, Poland, has made significant strides in the field of pharmacology, particularly focusing on treatments for neurological diseases and psychiatric disorders. With two patents to his name, Abram stands out as a key contributor to advancements in medical science.
Latest Patents
Abram's latest patents showcase his dedication to developing effective treatments without the adverse sedative effects commonly associated with such therapies. His first patent details "Modified amino acid derivatives for the treatment of neurological diseases and selected psychiatric disorders," specifically focusing on 2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2-oxopyrrolidin-1-yl)propanamide derivatives. These compounds exhibit broad-spectrum protective activities in animal models, addressing issues such as epileptic seizures, pain, depression, and anxiety. Notably, these derivatives have demonstrated neuroprotective effects in both in vitro and in vivo studies.
His second patent is centered around "(2,5-dioxopyrrolidin-1-yl)(phenyl)-acetamide derivatives and their use in the treatment of neurological diseases." The patent highlights the potential of compounds defined by a specific general formula as effective active ingredients in pharmaceutical compositions designed to treat epileptic seizures, neuropathic pain, or migraines.
Career Highlights
Throughout his career, Michal Abram has collaborated with prestigious institutions. Notably, he has worked at the Jagiellonian University, Poland’s oldest university, and at the Medical University of Warsaw, further establishing his academic credibility and influence in medical research.
Collaborations
Abram has had the privilege of working alongside esteemed colleagues, including Krzysztof Kaminski and Anna Rapacz. These collaborations highlight the importance of teamwork in driving forward innovative research and development in the pharmaceutical field.
Conclusion
Michal Abram exemplifies the pioneering spirit of modern inventors, harnessing scientific knowledge to develop solutions for complex neurological problems. His contributions through patents not only advance medical treatments but also pave the way for future research and discoveries in the field. With an unwavering commitment to innovation, Abram continues to play a crucial role in improving the lives of those affected by neurological and psychiatric conditions.